HAI Pathogens and Antimicrobial Resistance Report Data Tables, 2018-2021

Pediatric Data Tables

Print
PAGE 9 of 11

‹View Table of Contents

Related Pages

Table P8. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by Location Type, Pediatrics, 2018-2021

Table P8. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type, Pediatrics, 2018-2021
  NICUs Pediatric ICUs Pediatric Oncology Units Pediatric Wards
 Pathogen, Antimicrobial Phenotype # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R # Reported % Tested %R
Urgent Threats Acinetobacter spp. 28 46 42 32
Carbapenem-NS 75.0 4.8 80.4 0.0 78.6 3.0 75.0 0.0
Select Enterobacterales2 1,135 836 1,163 731
Carbapenem-resistant (CRE) 71.8 0.5 79.7 2.9 81.3 3.7 77.3 1.1
Serious Threats Select Enterobacterales3 946 547 957 546
Extended-spectrum cephalosporin-NS 83.1 10.4 87.4 24.3 88.5 34.9 87.0 20.2
Enterobacter spp. 167 275 193 171
Cefepime-NS 71.9 0.8 81.8 13.3 72.5 16.4 78.9 8.1
Enterococcus faecalis 511 553 225 238
Vancomycin-resistant (VRE) 89.6 0.2 87.5 0.0 80.9 1.1 84.5 0.0
Enterococcus faecium 22 109 130 49
Vancomycin-resistant (VRE) 90.9 5.0 92.7 21.8 90.0 37.6 93.9 30.4
Pseudomonas aeruginosa 144 178 217 97
Multidrug-resistant (MDR) 81.3 1.7 88.2 9.6 90.8 8.1 95.9 5.4
Staphylococcus aureus 1,346 511 281 324
Meth/ox/cefox – resistant (MRSA) 87.0 28.6 85.3 27.3 82.9 33.5 82.7 32.1

Note: Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.

Footnotes:

  1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]
  2. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.
  3. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs
  2. Table P1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table P2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table P3: The Top 15 HAI Pathogens Reported to NHSN
  5. Table P4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table P5. The Top 15 CAUTI Pathogens Reported to NHSN
  7. Table P6. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  8. Table P7. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  9. ›Table P8. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  10. Table P9. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats
  11. Table P10. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for High-volume Surgical Categories